Following is a summary of current health news briefs.
World's first baby born via womb transplant from dead donor
A woman in Brazil who received a womb transplanted from a deceased donor has given birth to a baby girl in the first successful case of its kind, doctors reported. The case, published in The Lancet medical journal, involved connecting veins from the donor uterus with the recipient's veins, as well as linking arteries, ligaments and vaginal canals.
More U.S. pregnant women using opioids and meth
A growing number of American pregnant women are using opioids and methamphetamines, and drug use is rising fastest among mothers in rural communities, a U.S. study suggests. Nationwide, between 2008-2009 and 2014-2015, the proportion of babies born exposed to amphetamines - mostly meth - doubled from 1.2 infants for every 1,000 hospital births to 2.4 infants out of every 1,000 hospital births, the study found. By the end of the study period, the highest proportion of babies exposed to meth was in the rural West, where 11.2 babies in every 1,000 were exposed to amphetamine.
Amgen Inc, updating the first trial of its bispecific antibody for multiple myeloma, said on Monday seven out of 10 patients given the second-highest dose of AMG420 responded to the drug, including four with no detectable cancer. Six patients were still responding at 7.5 months of follow-up, according to research presented in San Diego at the annual meeting of the American Society of Hematology (ASH).
China reports more African swine fever outbreaks in Beijing, Sichuan, Shaanxi
More African swine fever cases have been detected in the capital Beijing as well as in the provinces of Sichuan and Shaanxi, the agricultural ministry said on Wednesday. A total of 158 pigs were reported killed by the highly contagious disease at farms affected in these regions.
Hypnosis could help irritable bowel syndrome symptoms
Patients with irritable bowel syndrome may find that hypnotherapy helps them cope with their symptoms, a new study shows. Irritable bowel syndrome is a chronic gastrointestinal disorder with abdominal pain, stomach discomfort, altered bowel habits and other symptoms, the study authors explain in the journal Lancet Gastroenterology and Hepatology.
U.S. relies heavily on foreign-born healthcare workers
More than one in four doctors in the United States were born in another country, and a new study suggests many nurses, dentists, pharmacists, and home health aides are also immigrants. Researchers who analyzed U.S. census data on 164,000 health care professionals found that overall, almost 17 percent weren't born in America and almost five percent were not U.S. citizens.
Novartis's new treatment for hives outperforms Xolair in trials
Novartis said on Tuesday it was taking its experimental medicine ligelizumab to late-stage trials after the drug showed signs of outperforming existing product Xolair in treating severe urticaria, also known as hives. Xolair is sold by both Novartis and Roche, but has lost patent protection in Europe and the United States, leaving it exposed to rivals who are developing copies of the biological drug. None are yet on the market.
Bayer halts vilaprisan drug trials due to toxicology data
Bayer said it halted trials testing its experimental uterine fibroids treatment vilaprisan, which it previously expected to generate peak annual sales of more than 1 billion euros ($1.1 billion), citing the risk of side effects. "For vilaprisan we have just some days ago put clinical development of our ongoing trials on hold," said drug development head Joerg Moeller, speaking at the group's capital markets day in London.
Vietnam steps up measures to prevent African swine fever
Vietnamese authorities on Wednesday conducted drills to prevent the spread of African swine fever should there be an outbreak of the disease in the country, as the risks of transmission from neighboring China increase. The highly contagious fever has killed around a million pigs worldwide and recently spread rapidly across China, which has reported 80 cases since early August.
Roche's Tecentriq wins speedy U.S. FDA review for small cell lung cancer
Swiss group Roche Holding AG said on Wednesday its Tecentriq immunotherapy mixed with chemotherapy won priority review from the U.S. regulator for treating a type of lung cancer, a potential boost to the drug that has been trailing rivals' revenues. The announcement comes after Roche in September said patients with untreated extensive-stage small cell lung cancer (SCLC) lived a median 12.3 months after getting the Tecentriq cocktail, compared to 10.3 months for those getting chemotherapy alone.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)